Walleye Capital’s Apexigen, Inc. Common Stock APGN Stock Holding History

Walleye Capital’s Portfolio APGN Stock Details APGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-42,934	Closed	-$349K	–	3657
2022 Q2	$436K	Buy	+42,934	New	+$435K	0.01%	1115
2022 Q1	–	Sell	-14,536	Closed	-$146K	–	2732
2021 Q4	$146K	Buy	+14,536	New	+$145K	﹤0.01%	1575

Other funds holding APGN

DCMIC

Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

Yu Fan $97M AUM 57.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Walleye Capital's APGN Position: Q3 2022 in Review

Walleye Capital sold out of Apexigen, Inc. Common Stock (APGN) in Q3 2022, closing a stake of 42,934 shares — an estimated $349K sold.

Walleye Capital first reported a position in APGN in Q4 2021 and held it in 2 quarters. The position peaked at $436K in Q2 2022. 18 funds tracked by Wall St. Rank hold APGN as of Q3 2022.

Walleye Capital reported no remaining Apexigen, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Walleye Capital sold 42,934 Apexigen, Inc. Common Stock shares in Q3 2022, an estimated $349K.
Walleye Capital first reported a position in Apexigen, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
Walleye Capital's Apexigen, Inc. Common Stock position peaked at $436K in Q2 2022.
18 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q3 2022.

Based on Walleye Capital's 13F filing for Q3 2022, filed 14 Nov 2022.